EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research
April 18, 2024
| EditCo
REDWOOD CITY, CA, April 18, 2024 – EditCo Bio, Inc., a pioneer at the forefront of genome engineering innovation, today announced the launch of its...
Read More